Search liu.se

A new study has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by an existing drug.

A certain gene that is passive can cause leucemia or other cancer. But activated, it can increase the response of treatments that are already today in practice.